CD79 Antibodies

Santa Cruz Biotechnology features a diverse variety of CD79 monoclonal antibodies for immunology and cell biology research. CD79 monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). CD79 is a crucial component of the B-cell receptor complex, playing a significant role in B-cell activation and signaling. CD79 functions are essential for the development and function of B lymphocytes, which are vital for adaptive immunity. Understanding CD79's role in immune responses can provide insights into various diseases, including autoimmune disorders and lymphomas. CD79 monoclonal antibodies enable detailed examination of B-cell development, activation, and function in both normal and pathological conditions. Research utilizing CD79 monoclonal antibodies contributes to advancing our understanding of immune system regulation and potential therapeutic approaches. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing scientific knowledge and developing innovative solutions in immunology and cell biology.